TBA-354

DRUG2 trials

Sponsors

Global Alliance for TB Drug Development

Conditions

Tuberculosis

Phase 1

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

CompletedNCT02288481

Global Alliance for TB Drug DevelopmentTuberculosis

Start: 2015-01-31End: 2015-06-30Updated: 2019-09-06

A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

TerminatedNCT02606214

Global Alliance for TB Drug DevelopmentTuberculosis

Start: 2015-11-30End: 2016-12-31Updated: 2019-09-18